Business Description
Ascentage Pharma Group International
ISIN : KYG0519B1023
Compare
Compare
Traded in other countries / regions
06855.Hong KongASPHF.USA36X.Germany IPO Date
2020-12-29Description
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.
Financial Strength
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.6 | |||||
Equity-to-Asset | 0.02 | |||||
Debt-to-Equity | 29.72 | |||||
Debt-to-EBITDA | -2.22 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -2.31 | |||||
Beneish M-Score | -1.6 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 133 | |||||
3-Year EBITDA Growth Rate | 6.5 | |||||
3-Year EPS without NRI Growth Rate | 1 | |||||
3-Year FCF Growth Rate | 13.8 | |||||
3-Year Book Growth Rate | -62.8 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 99.95 | |||||
9-Day RSI | 98.43 | |||||
14-Day RSI | 91.89 | |||||
6-1 Month Momentum % | 1.89 | |||||
12-1 Month Momentum % | -34.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.44 | |||||
Quick Ratio | 1.42 | |||||
Cash Ratio | 1.14 | |||||
Days Inventory | 122.83 | |||||
Days Sales Outstanding | 155.11 | |||||
Days Payable | 867.29 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.7 | |||||
Shareholder Yield % | -7.43 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 86.24 | |||||
Operating Margin % | -393.11 | |||||
Net Margin % | -416.98 | |||||
FCF Margin % | -352.83 | |||||
ROE % | -260.12 | |||||
ROA % | -33.42 | |||||
ROIC % | -49.42 | |||||
ROC (Joel Greenblatt) % | -111.38 | |||||
ROCE % | -43.05 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 26.56 | |||||
PB Ratio | 101.1 | |||||
EV-to-EBIT | -8.18 | |||||
EV-to-EBITDA | -8.45 | |||||
EV-to-Revenue | 30.84 | |||||
EV-to-FCF | -8.74 | |||||
Earnings Yield (Greenblatt) % | -12.22 | |||||
FCF Yield % | -12.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ASPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ascentage Pharma Group International Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 31.03 | ||
EPS (TTM) ($) | -0.458 | ||
Beta | 0.47 | ||
Volatility % | 34.53 | ||
14-Day RSI | 91.89 | ||
14-Day ATR ($) | 0.00273 | ||
20-Day SMA ($) | 2.69 | ||
12-1 Month Momentum % | -34.55 | ||
52-Week Range ($) | 2.35 - 4.11 | ||
Shares Outstanding (Mil) | 290.2 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Ascentage Pharma Group International Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Ascentage Pharma Group International Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Ascentage Pharma Group International Frequently Asked Questions
What is Ascentage Pharma Group International(ASPHF)'s stock price today?
The current price of ASPHF is $2.69. The 52 week high of ASPHF is $4.11 and 52 week low is $2.35.
When is next earnings date of Ascentage Pharma Group International(ASPHF)?
The next earnings date of Ascentage Pharma Group International(ASPHF) is 2024-08-21 Est..
Does Ascentage Pharma Group International(ASPHF) pay dividends? If so, how much?
Ascentage Pharma Group International(ASPHF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |